Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Dissecting the Hierarchy of Tumor Cell Differentiation Using Dual Recombinase Technology in a Novel Mouse Model of Rhabdomyosarcoma |
Duke University Medical Center / David Van Mater, MD, PhD |
Young Investigator Grants |
2013 |
North Carolina |
Engager T Cells: A Novel Immunotherapeutic for AML |
University of Michigan / Challice Bonifant, MD, PhD |
Young Investigator Grants |
2015 |
Michigan |
Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Sarah Tasian |
Young Investigator Grants |
2012 |
Pennsylvania |
MicroRNAs 100 and 125b in Ewing sarcoma |
University of Colorado Denver / Paul Jedlicka |
Young Investigator Grants |
2010 |
Colorado |
Novel Genomic Drivers in Pediatric Polyposis Syndromes |
Children’s Hospital of Philadelphia / Suzanne MacFarland, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children’s Hospital of Philadelphia / Jenny Ruiz, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML |
Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD |
Young Investigator Grants |
2018 |
Massachusetts |
The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia |
The Johns Hopkins University School of Medicine / Stacy Cooper, MD |
Young Investigator Grants |
2015 |
Maryland |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |